Who is sponsoring NCT06696638?

NCT06696638 is sponsored by XiaoJing Zou,MD.

What drugs are being tested in NCT06696638?

Interventions in NCT06696638: EIT-guided Phigh settings during APRV.

What condition does NCT06696638 study?

NCT06696638 studies ARDS: Acute Respiratory Distress Syndrome.

Is NCT06696638 still recruiting?

NCT06696638 is currently recruiting now. Last updated 6 January 2025.

Last reviewed 2025-01-06 · How we verify

NCT06696638

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Physiological Effects of Lung Impedance Tomography-Guided and Plat Pressure-Guided Phigh During APRV in Patients With ARDS

Recruiting now NA Last updated 6 January 2025

What this trial tests

NA trial testing EIT-guided Phigh settings during APRV in ARDS: Acute Respiratory Distress Syndrome in 26 participants. Currently enrolling.

Timeline

1 January 2025

Primary endpoint
31 December 2026

31 December 2026

Quick facts

Lead sponsor	XiaoJing Zou,MD
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	26
Start date	1 January 2025
Primary completion	31 December 2026
Estimated completion	31 December 2026
Sites	1 location across China

Drugs / interventions tested

EIT-guided Phigh settings during APRV

Conditions studied

ARDS: Acute Respiratory Distress Syndrome — all drugs for ARDS: Acute Respiratory Distress Syndrome →

Sponsor

XiaoJing Zou,MD

Who can join

18 and older, any sex, with ARDS: Acute Respiratory Distress Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the effects of EIT-guided and Pplat-guided Phigh settings on regional ventilation and perfusion in ARDS patients during APRV, while also examining the impact of different Phigh settings on gas exchange, respiratory mechanics, and hemodynamics.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other XiaoJing Zou,MD trials

Trials by the same sponsor.

NCT06967207 — Electrical Impedance Tomography-Based Prognostic Model for ARDS · recruiting
NCT06697717 — End-expiratory Transpulmonary Pressure-guided vs Electrical Impedance Tomography-guided PEEP Titration Methods in Patien · NA · recruiting
NCT05922631 — Effect of APRV vs. LTV on Right Heart Function in ARDS Patients: a Single-center Randomized Controlled Study · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06696638 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by XiaoJing Zou,MD
Last refreshed: 6 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06696638.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing